BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 19843266)

  • 1. Use of performance- and image-enhancing substances among recreational athletes: a quantitative analysis of inquiries submitted to the Danish anti-doping authorities.
    Bojsen-Møller J; Christiansen AV
    Scand J Med Sci Sports; 2010 Dec; 20(6):861-7. PubMed ID: 19843266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Doping in recreational sports activities--pills for better performance].
    Weiss J
    Dtsch Med Wochenschr; 2012 Jul; 137(30):p24. PubMed ID: 22872512
    [No Abstract]   [Full Text] [Related]  

  • 3. Self-reported attitudes of elite athletes towards doping: differences between type of sport.
    Alaranta A; Alaranta H; Holmila J; Palmu P; Pietilä K; Helenius I
    Int J Sports Med; 2006 Oct; 27(10):842-6. PubMed ID: 16586338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anabolic steroid use in adolescents: identification of those at risk and strategies for prevention.
    Mulcahey MK; Schiller JR; Hulstyn MJ
    Phys Sportsmed; 2010 Oct; 38(3):105-13. PubMed ID: 20959703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Medication, athletes and doping regulations].
    Hartgens F
    Ned Tijdschr Geneeskd; 2008 Aug; 152(33):1844-8. PubMed ID: 18783164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Between medical treatment and performance enhancement: an investigation of how elite athletes experience Therapeutic Use Exemptions.
    Overbye M; Wagner U
    Int J Drug Policy; 2013 Nov; 24(6):579-88. PubMed ID: 23582632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Doctors belonging to the Senegalese Association of Sport Medicine and doping in sports: survey on knowledge and attitudes].
    Dièye AM; Diallo B; Fall A; Ndiaye M; Cissè F; Faye B
    Sante; 2005; 15(3):167-70. PubMed ID: 16207578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Androgenic-anabolic steroids and the Olympic Games.
    Fitch KD
    Asian J Androl; 2008 May; 10(3):384-90. PubMed ID: 18385900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anabolic-androgenic steroid use among young male and female athletes: is the game to blame?
    Harmer PA
    Br J Sports Med; 2010 Jan; 44(1):26-31. PubMed ID: 19919946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anabolic steroids in sport.
    VanHelder WP; Kofman E; Tremblay MS
    Can J Sport Sci; 1991 Dec; 16(4):248-57. PubMed ID: 1663826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Athletes' perceptions toward substance use in Baghdad city.
    Habeeb MB; Kasim WJ; Khamees LA; Hawi MM; Khashoom QN
    Am J Mens Health; 2012 Nov; 6(6):462-71. PubMed ID: 22713800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug testing in elite athletes--the Israeli perspective.
    Epstein S; Eliakim A
    Isr Med Assoc J; 1999 Oct; 1(2):79-82. PubMed ID: 10731300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medicine and science in the fight against doping in sport.
    Catlin DH; Fitch KD; Ljungqvist A
    J Intern Med; 2008 Aug; 264(2):99-114. PubMed ID: 18702750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting future anabolic-androgenic steroid use intentions with current substance use: findings from an internet-based survey.
    Dunn M; Mazanov J; Sitharthan G
    Clin J Sport Med; 2009 May; 19(3):222-7. PubMed ID: 19423975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contaminated nutritional supplements--legal protection for elite athletes who tested positive: a case report from Germany.
    Striegel H; Vollkommer G; Horstmann T; Niess AM
    J Sports Sci; 2005 Jul; 23(7):723-6. PubMed ID: 16195022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Doping, drugs and drug abuse among adolescents in the State of Thuringia (Germany): prevalence, knowledge and attitudes.
    Wanjek B; Rosendahl J; Strauss B; Gabriel HH
    Int J Sports Med; 2007 Apr; 28(4):346-53. PubMed ID: 17024651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anabolic-androgenic steroids: use and abuse in pediatric patients.
    Kerr JM; Congeni JA
    Pediatr Clin North Am; 2007 Aug; 54(4):771-85, xii. PubMed ID: 17723876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Australian athletes' knowledge of the WADA Prohibited Substances List and performance enhancing substances.
    Orr R; Grassmayr M; Macniven R; Grunseit A; Halaki M; Bauman A
    Int J Drug Policy; 2018 Jun; 56():40-45. PubMed ID: 29550541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Doping and musculoskeletal system: short-term and long-lasting effects of doping agents.
    Nikolopoulos DD; Spiliopoulou C; Theocharis SE
    Fundam Clin Pharmacol; 2011 Oct; 25(5):535-63. PubMed ID: 21039821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance-enhancing drugs and supplements in women and girls.
    Matich AJ
    Curr Sports Med Rep; 2007 Dec; 6(6):387-91. PubMed ID: 18001612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.